IP Library › Granted Patent US 7,094,881
Granted Patent B2
US 7,094,881 · App. 10/640,326 · Granted Aug 22, 2006

Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,094,881
App. No.
10/640,326
Granted
Aug 22, 2006
Kind
B2
Abstract

The present invention provides amino acid sequences of peptides that are encoded by genes within the human genome, the protease peptides of the present invention. The present invention specifically provides isolated peptide and nucleic acid molecules, methods of identifying orthologs and paralogs of the protease peptides, and methods of identifying modulators of the protease peptides.

Claims (20)

1. An isolated antibody that selectively binds to a polypeptide wherein the amino acid sequence of said polypeptide consists of SEO ID NO:2.

2. An Isolated antibody that selectively binds to a polypeptide, wherein the amino acid sequence of said polypeptide comprises SEQ ID NO:2.

3. The antibody of claim 2 , wherein the antibody is a monoclonal antibody.

4. The antibody of claim 3 , wherein the antibody is coupled to a detectable substance.

5. A composition comprising the antibody of claim 3 and a pharmaceutically acceptable carrier.

6. The antibody of claim 2 , wherein the antibody is coupled to a detectable substance.

7. A composition comprising the antibody of claim 2 and a pharmaceutically acceptable carrier.

8. The antibody of claim 1 , wherein the antibody is a monoclonal antibody.

9. The antibody of claim 8 , wherein the antibody is coupled to a detectable substance.

10. A composition comprising the antibody of claim 8 and a pharmaceutically acceptable carrier.

11. The antibody of claim 1 , wherein the antibody is coupled to a detectable substance.

12. A composition comprising the antibody of claim 1 and a pharmaceutically acceptable carrier.

13. An isolated antibody fragment that selectively binds to apolypeptide, wherein the amino acid sequence of said polypeptide consists of SEQ ID NO:2, and wherein the antibody fragment comprises a fragment selected from the group consisting of:

a) an Fab fragment;

b) an F(ab′) 2 fragment; and

c) an Fv fragment.

14. An isolated antibody fragment that selectively binds to apolypeptide, wherein the amino acid sequence of said polypeptide composes SEQ ID NO:2, and wherein the antibody fragment comprises a fragment selected from the group consisting of:

a) an Fab fragment;

b) an F(ab′) 2 fragment; and

c) an Fv fragment.